Improving Clinical Trial Design and Investment Allocation

Annually, $60 billion is invested into clinical trials, with each trial averaging $48 million. Despite this, only 10% of pivotal trials succeed, mainly due to poor design. Amendments, costing an average of $453,932 each, lead to significant delays and expenses.
 

TrialKey leverages a real-world dataset of over 350,000 trials to provide AI-driven trial design simulation and optimisation recommendations. Using our world-first simulator, companies can design trials, get instant competitor comparisons, and receive market-leading success predictions

TrialKey’s AI technology drastically improves clinical trial design and execution with over 90% accuracy. Our platform delivers tailored, actionable insights, enhancing success rates, reducing time delays, and improving resource allocation.

Mission

Our mission is to make a meaningful difference in medicine by leveraging AI to refine recommendations, optimise trial designs, and pioneer innovative solutions that address broader medical challenges.

Vision

To be positioned as the gold standard platform for clinical trial design optimisation and prediction worldwide.

Our Leadership Team

THEO VORONOV
THEO VORONOV PARTNER — ADVANTAGE DATA
DR EUGENE DUBBOSARKYK
DR EUGENE DUBBOSARKYK PARTNER — ADVANTAGE DATA

Optimise Clinical Trial Design and Investment Allocation

TrialKey stands as the market leader for clinical trial prediction and design optimisation, with an accuracy rate of +90%